Archived Press Releases 11/15/07   BioVex Closes Second Round of Series E Financing 11/7/07   Oxford Finance Corporation and GE Healthcare Financial Services Reaffirm Commitment to Biotech Sector in Europe 9/25/07   Oxford Finance Corporation Closes $7 Million Debt Facility with Othera Pharmaceuticals 9/17/07   Oxford Finance Corporation Sponsors 2007 Mid-Atlantic Bio 9/17/07   Entremed Raises $20 Million to Support Clinical Development Program 9/12/07   Oxford Finance Corporation Hires Timothy A. Lex to Serve as Chief Operation Officer 8/21/07   CryoCor Completes New Credit Facility 7/17/07 Rubicor Medical, Inc. Receives $10 Million in Financing to Further Growth Opportunity 11/27/06 Alba Therapeutics Corporation Announces $10 million in Financing 1/23/06 Oxford Finance Corporation Establishes Prestigious Scientific Advisory Board. 11/29/05 Oxford Finance Corporation Hires Executive to Cultivate European Market. 11/21/05 Sembiosys Executes $2,500,000 Debt Financing Agreement. 11/17/04 Protana Announces Completion of Debt Financing Deal 10/12/04 Nucleonics Secures $2.7M Equipment Financing Facility 6/15/04 Sumitomo Corporation of America Completes Acquisition of Oxford Finance Corporation 1/29/04 Sumitomo Corporation of America to Acquire Oxford Finance Corporation 12/3/03 Oxford Finance Corporation Declares Fourth Quarter Dividend of $0.15 Per Share 11/14/03 Oxford Finance Corporation Declares Third Quarter 2003 Financial Results 9/3/03 Oxford Finance Corporation Declares Third Quarter Dividend of $0.11 Per Share 8/15/03 Oxford Finance Corporation Appoints Richard J. Hendrix and Joseph C. Lane to Its Board of Directors 8/14/03 Oxford Finance Announces Second Quarter 2003 Financial Results 6/2/03 Oxford Finance Corporation Declares Second Quarter Dividends Totaling $0.19 Per Share, Including a Special Dividend 5/15/03 Oxford Finance Announces First Quarter 2003 Financial Results 3/4/03 Oxford Finance Corporation Declares Dividend of $0.07 Per Share